The EANM guideline on radioiodine therapy of benign thyroid disease.
Level V
Where this comes from
- Record sourced from PubMed, PMID 37395802.
- Also identified by DOI 10.1007/s00259-023-06274-5 and PMC identifier 10542302.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients' preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.
Medical subject headings
- Graves Disease
- Thyroid Diseases
- Radiation Protection